Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Features of FeNO-high asthma phenotype

Francesca Bertolini, Andrea Elio Sprio, Elisa Riccardi, Andrea Baroso, Vitina Carriero, Fabio Luigi Massimo Ricciardolo
European Respiratory Journal 2021 58: PA3711; DOI: 10.1183/13993003.congress-2021.PA3711
Francesca Bertolini
1Severe Asthma Centre, Rare Lung Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga University Hospital, University of Torino, Italy., Orbassano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: francesca.bertolini@unito.it
Andrea Elio Sprio
1Severe Asthma Centre, Rare Lung Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga University Hospital, University of Torino, Italy., Orbassano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Riccardi
1Severe Asthma Centre, Rare Lung Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga University Hospital, University of Torino, Italy., Orbassano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Baroso
1Severe Asthma Centre, Rare Lung Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga University Hospital, University of Torino, Italy., Orbassano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vitina Carriero
1Severe Asthma Centre, Rare Lung Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga University Hospital, University of Torino, Italy., Orbassano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabio Luigi Massimo Ricciardolo
1Severe Asthma Centre, Rare Lung Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga University Hospital, University of Torino, Italy., Orbassano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 58 no. suppl 65
DOI 
https://doi.org/10.1183/13993003.congress-2021.PA3711

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online November 25, 2021.

Copyright & Usage 
Copyright ©the authors 2021

Author Information

  1. Francesca Bertolini1⇑,
  2. Andrea Elio Sprio1,
  3. Elisa Riccardi1,
  4. Andrea Baroso1,
  5. Vitina Carriero1 and
  6. Fabio Luigi Massimo Ricciardolo1
  1. 1Severe Asthma Centre, Rare Lung Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga University Hospital, University of Torino, Italy., Orbassano, Italy
  1. Francesca Bertolini, Severe Asthma Centre, Rare Lung Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga University Hospital, University of Torino, Italy., Orbassano, Italy. E-mail: francesca.bertolini{at}unito.it

Article usage

Article usage: November 2021 to February 2023

AbstractFullPdf
Nov 20213800
Dec 20215200
Jan 20222800
Feb 20221000
Mar 20222000
Apr 20222200
May 20221800
Jun 20221700
Jul 2022700
Aug 20221100
Sep 20222100
Oct 20221100
Nov 20221600
Dec 2022900
Jan 2023900
Feb 20231100

Altmetrics

Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Features of FeNO-high asthma phenotype
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Features of FeNO-high asthma phenotype
Francesca Bertolini, Andrea Elio Sprio, Elisa Riccardi, Andrea Baroso, Vitina Carriero, Fabio Luigi Massimo Ricciardolo
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3711; DOI: 10.1183/13993003.congress-2021.PA3711

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Features of FeNO-high asthma phenotype
Francesca Bertolini, Andrea Elio Sprio, Elisa Riccardi, Andrea Baroso, Vitina Carriero, Fabio Luigi Massimo Ricciardolo
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3711; DOI: 10.1183/13993003.congress-2021.PA3711
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis
  • Heterogeneity and time course of asthma exacerbations: data from AUSTRI
  • Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Show more Monitoring airway disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society